NEW YORK, Feb. 3, 2014 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
Generic Drugs: Global collaboration opportunities
http://www.reportlinker.com/p0703654/Generic-Drugs-Global-collaboration-opportunities .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Generic_Drug
Key facts, statistics and insights on 160 medium-sized generic manufacturers based in 42 countries!
Collaboration is the key to growth
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector Even markets traditionally based in the provision of branded medicines have made moves to increase generic prescribing
But pressure on health spending is seeing downward pressure on generic prices With lower margins this is creating pain for generics companies
SME Generic companies offer focused opportunities
With established markets compromised, where can the industry go? Expansion in the sector has been seen through more partnering, either through outright acquisition to increase market share or through product and marketing licensing Being bigger and having improved market access is seen as a way of distributing cost and strengthening revenues While major players such as Teva and Sandoz play an international role, there are a number of established and progressive generic manufacturers worthy of consideration
Use this report to…
Identify commercial partners to secure new markets, technologies and revenues
Assess merger and acquisition targets
Understand the developing generic industry in key markets worldwide
Profile the competitive environment in the increasingly important medium-sized company sector
Seek out companies manufacturing/marketing similar product lines
Assess the investment potential of these key companies
Find and assess potential partners and acquisition targets with this report
This new report from Espicom is a key resource for the wide assessment of 160 medium-sized generic companies operating in 42 markets worldwide The report provides an essential and comprehensive evaluation of each company:
Location, establishment and full contact details Financial information, where available Products and/or therapy areas Recent strategic alliancesDelivering the key content you need
• Background
A summary of the company's foundation and main business interests
• Product rangeDetails of ANDAs approved or products/therapy areas represented
• Financial
Financial performance or funding data
• Strategic alliancesDetails of significant marketing and supply agreements
• Contact information
Postal, telephone, fax and website details
About the Author:
Generic Drugs: Global Collaboration Opportunities has been researched and written by Espicom editor Ian Platts In addition to this report, Ian edits the leading newsletter World Generic Markets and has monitored the generics market for over 10 years
Other reports in the series:
World Generic Market Report
(June 2013) VOLUME I: COMPANY PROFILES & VOLUME II: COUNTRY PROFILES
A complete global analysis of the prospects for markets and companies in this dynamic industry sector
Biosimilar Opportunities in an Evolving Market
(August 2013)
The long awaited promise of biosimilars takes another step to fulfilment with the first approval in Europe of high-value second generation products But what products can be expected to follow, who is developing them and what are the hot prospects?
Inhalation & Nasal Spray Generic Drugs
(November 2013)
Comprehensive overview of the challenges and opportunities across the respiratory drugs market, and the FDA's new product guidance forgeneric inhalers
Contents
Companies In This Report1Company Details In Focus8Argentina17Laboratorios Phoenix17Snapshot 17Background 17Products 17Major Developments 17Contact Details18Australia 19Alchemia19Snapshot 19Background19Products19Financials20Major Developments20Contact Details21Bangladesh22Beximco Pharmaceuticals 22Snapshot 22Background22Products22Financials23Major Developments23Contact Details24Brazil 25Hypermarcas25Snapshot 25Background25Products25Financials25Major Developments26Contact Details27LAFEPE28Snapshot 28Background28Products28Major Developments29Contact Details29moksha830Snapshot 30Background30Products30Major Developments30Contact Details31Bulgaria32Sopharma32Snapshot 32Background32Products32iiiGeneric Drugsiv
Financials32
Contact Details33
Canada 34
AA Pharma34
Snapshot 34
Background34
Products34
Contact Details35
BioVectra 36
Snapshot 36
Background36
Products36
Major Developments36
Contact Details37
Intellipharmaceutics International 38
Snapshot 38
Background38
Products38
Financials38
Major Developments39
Contact Details40
Chile41
CFR Pharmaceuticals 41
Snapshot 41
Background41
Products42
Financials42
Major Developments42
Contact Details43
China 44
Aoxing Pharmaceutical44
Snapshot 44
Background 44
Products 44
Financials 44
Major Developments45
Contact Details 46
China Pharma Holdings 47
Snapshot 47
Background47
Products47
Financials47
Contact Details 48
Rxmidas/GRMIDAS 49
Snapshot 49
Background49
Products49
Financials49
Major Developments49
Contact Details50
Zhejiang Huahai Pharmaceuticals 51
Snapshot 51
Background51
v
Products51Contact Details51Cyprus 52Medochemie 52Snapshot 52Background52Products52Contact Details52Egypt 53EIPICo 53Snapshot 53Background53Products53Contact Details53France 54BioAlliance Pharma54Snapshot 54Background54Financials55Major Developments55Contact Details57Germa ny 58Alfred E Tiefenbacher (AET) 58Snapshot 58Background58Products58Major developments58Contact Details59Fresenius Kabi60Snapshot 60Background60Products60Financials 62Major Developments62Contact Details 64Greece 65Genepharm 65Snapshot 65Background65Products65Contact Details66Pharmathen 67Snapshot 67Background67Products67Financials67Contact Details67India 68Alembic 68Snapshot 68Background68vi
Products68
Financials69
Major Developments70
Contact Details71
Alkem 72
Snapshot 72
Background72
Products72
Major Developments73
Contact Details73
Bafna Pharmaceuticals 74
Snapshot 74
Background74
Products74
Financials75
Major Developments75
Contact Details76
Bharat Serums and Vaccines 77
Snapshot 77
Background77
Products77
Contact Details78
Biocon 79
Snapshot 79
Background79
Products79
Financials80
Major Developments81
Contact Details83
Claris Lifesciences84
Snapshot 84
Background 84
Products 84
Financials85
Major Developments86
Contact Details87
Emcure88
Snapshot 88
Background88
Products88
Major Developments89
Contact Details89
Gland Pharma90
Snapshot 90
Background90
Products90
Major Developments90
Contact Details91
Glenmark Pharmaceuticals 92
Snapshot 92
Background92
Products92
Financials94
Major Developments96
Contact Details97
vii
Granules India 98Snapshot 98Background98Products98Financials99Major Developments99Contact Details99Hetero Drugs100Snapshot 100Background 100Products 100Major Developments 101Contact Details 103Indoco Remedies 104Snapshot104Background 104Products104Financials 105Major Developments 105Contact Details 106Intas Pharmaceuticals 107Snapshot107Background 107Products107Financials 108Major Developments 108Contact Details 109Ipca Laboratories110Snapshot110Background 110Products110Financials 110Contact Details 112JB Chemicals & Pharmaceuticals 113Snapshot113Background 113Products113Financials 113Major Developments 114Contact Details 115Jubilant Life Sciences 116Snapshot116Background 116Products116Financials 117Major Developments 118Contact Details 119Macleods Pharmaceuticals 120Snapshot120Background 120Products120Contact Details 121Marksans Pharma 122Snapshot122Background 122viii
Products122
Financials 122
Contact Details 123
Micro Labs 124
Snapshot124
Background 124
Products124
Major Developments 124
Contact Details 125
Natco Pharma 126
Snapshot126
Background 126
Products126
Financials 127
Major Developments 128
Contact Details 130
Orchid Chemicals & Pharmaceuticals 131
Snapshot131
Background 131
Products131
Financials 133
Major Developments 133
Contact Details 134
RPG Life Sciences 135
Snapshot135
Background 135
Products135
Financials 135
Major Developments 136
Contact Details 136
Shasun Pharmaceuticals 137
Snapshot137
Background 137
Products137
Financials 137
Major Developments 138
Contact Details 139
Strides Arcolab140
Snapshot140
Background 140
Products140
Financials 142
Major Developments 143
Contact Details 145
Torrent Pharmaceuticals 146
Snapshot146
Background 146
Products146
Financials 147
Major Developments 148
Contact Details 149
Unichem Laboratories 150
Snapshot150
Background 150
Products150
ix
Financials 151Major Developments 152Contact Details 152Venus Remedies 153Snapshot153Background 153Products153Financials 153Major Developments 154Contact Details 154Ireland155Consilient Health 155Snapshot155Background 155Products155Contact Details 156Reliance GeneMedix 157Snapshot157Background 157Products157Financials 157Major Developments 158Contact Details 159Italy 160ACS Dobfar160Snapshot160Background 160Products160Contact Details 161Japa n 162Nichi-Iko Pharmaceutical 162Snapshot162Background 162Products162Financials 162Major Developments 163Contact Details 163Nippon Chemiphar 164Snapshot164Background 164Products164Financials 164Contact Details 165Towa Pharmaceutical166Snapshot166Background 166Products166Financials 166Contact Details 167Jorda n 168Hikma Pharmaceuticals168Snapshot168x
Background 168
Products168
Financials 171
Major Developments 171
Contact Details 175
Kenya176
Regal Pharmaceuticals 176
Snapshot176
Background 176
Products176
Contact Details 176
La tvia 177
Grindeks 177
Snapshot177
Background 177
Products177
Financials 177
Major Developments 178
Contact Details 179
Lithuania 180
Sanitas180
Snapshot180
Background 180
Products180
Financials 181
Major Developments 182
Contact Details 182
Malaysia 183
CCM Pharmaceuticals 183
Snapshot183
Background 183
Products183
Financials 184
Major Developments 184
Contact Details 185
Malaysia 186
Inno Biologics 186
Snapshot186
Background 186
Products186
Contact Details 187
Pharmaniaga Berhad188
Snapshot188
Background 188
Products188
Financials 188
Major Developments 189
Contact Details 189
Mexic o 190
Genomma Lab190
Snapshot190
xi
Background 190Products190Financials 190Contact Details 191Netherlands 192Genmed Holding 192Snapshot192Background 192Products192Financials 192Major Developments 193Contact Details 193Synthon194Snapshot194Background 194Products194Major Developments 195Contact Details 196New Zealand 197Douglas Pharmaceuticals 197Snapshot197Background 197Products197Financials 197Contact Details 198Norway 199Navamedic199Snapshot199Background 199Products199Financials 200Major Developments 200Contact Details 201Oma n 202Oman Pharmaceutical Products202Snapshot 202Background 202Products 202Major Developments 202Contact Details 203Poland 204Polpharma 204Snapshot 204Background 204Products 204Major Developments 204Contact Details 206Portugal 207Hovione207Snapshot 207Background 207xii
Products 207
Financials 208
Major Developments 208
Litigation 208
Contact Details 208
Roma nia 209
Antibiotice 209
Snapshot 209
Background 209
Products 209
Financials 209
Major Developments 210
Contact Details 210
Russia 211
R-Pharm211
Snapshot211
Background 211
Products211
Financials 211
Major Developments 212
Contact Details 212
South Africa 213
Adcock Ingram 213
Snapshot213
Background 213
Products214
Financials 216
Major Developments 218
Contact Details 221
Cipla Medpro222
Snapshot 222
Background 222
Products 222
Financials 223
Major Developments 224
Contact Details 225
Litha Healthcare226
Snapshot 226
Background 226
Products 226
Financials 226
Major Developments 227
Contact Details 228
Pharma Dynamics229
Snapshot 229
Background 229
Products 229
Contact Details 229
Sonke Pharmaceuticals230
Snapshot 230
Background 230
Products 230
Major Developments 230
xiii
Contact Details 231South Korea 232Hanmi Pharmaceutical232Snapshot232Background 232Products232Financials 233Major Developments 234Contact Details 236Spai n 237Laboratorios Cinfa237Snapshot237Background 237Products237Financials 237Major Developments 238Contact Details 238Sweden 239Bluefish Pharmaceuticals239Snapshot 239Background 239Products 239Financials 239Major Developments 240Contact Details 241Switzerland 242Acino242Snapshot 242Background 242Products 242Financials 243Major Developments 243Contact Details 245Legacy Pharmaceuticals International 246Snapshot 246Background 246Products 246Contact Details 246Tai wan 247ScinoPharm Taiwan 247Snapshot247Background 247Products 248Financials 248Major Developments 249Contact Details 250Thailand 251Government Pharmaceutical Organisation251Snapshot251Background 251Products251xiv
Contact Details 252
Turkey 253
Abdi Ibrahim253
Snapshot253
Background 253
Products253
Major Developments 254
Contact Details 254
EastPharma255
Snapshot255
Background 255
Products255
Financials 255
Contact Details 256
Mustafa Nevzat Pharmaceuticals 257
Snapshot257
Background 257
Products257
Major Developments 258
Contact Details 258
UK 259
Amdipharm Mercury (AMCo)259
Snapshot 259
Background 259
Products 260
Financials 260
Major Developments 261
Contact Details 261
Kent Pharmaceuticals262
Snapshot 262
Background 262
Products 262
Major Developments 262
Contact Details 263
Syntropharma264
Snapshot 264
Background 264
Products 264
Major Developments 264
Contact Details 265
USA 266
Acella Pharmaceuticals266
Snapshot 266
Background 266
Products 266
Contact Details 266
Aceto267
Snapshot267
Background 267
Products267
Financials 267
Contact Details 268
Akorn269
xv
Snapshot 269Background 269Products270Financials 271Major Developments 272Contact Details 273Alvogen 274Snapshot274Background 274Products274Major Developments 275Contact Details 277Amerigen Pharmaceuticals278Snapshot278Background 278Products278Major Developments 278Contact Details 280Amneal Pharmaceuticals281Snapshot281Background 281Products281Major Developments 283Contact Details 284Amphastar Pharmaceuticals 285Snapshot 285Background 285Products 285Major Developments 286Contact Details 287Antares Pharma288Snapshot 288Background 288Products 288Financials 289Major Developments 289Contact Details 290Apicore291Snapshot291Background 291Products291Contact Details 292AustarPharma293Snapshot 293Background 293Products 293Major Developments 293Contact Details 294Avanthi295Snapshot 295Background 295Products 295Contact Details 295Bedford Laboratories296Snapshot 296xvi
Background 296
Products 296
Major Developments 298
Contact Details 299
Belcher Pharmaceuticals300
Snapshot 300
Background 300
Products 300
Contact Details 300
Biokey 301
Snapshot301
Background 301
Products301
Contact Details 301
Boca Pharmacal 302
Snapshot302
Background 302
Products302
Major Developments 302
Contact Details 303
Breckenridge Pharmaceutical 304
Snapshot 304
Background 304
Products 304
Major Developments 304
Contact Details 306
Cambrex 307
Snapshot307
Background 307
Products307
Financials 307
Major Developments 308
Contact Details 309
Carlsbad Technology 310
Snapshot310
Background 310
Products310
Contact Details 310
Cephazone Pharma 311
Snapshot311
Background 311
Products311
Contact Details 311
CorePharma 312
Snapshot312
Background 312
Products312
Major Developments 313
Contact Details 313
Cypress Pharmaceutical 314
Snapshot314
Background 314
Products314
Major Developments 314
Contact Details 315
xvii
Elite Pharmaceuticals 316Snapshot316Background 316Products316Financials 316Major Developments 317Contact Details 318Epic Pharma 319Snapshot319Background 319Products319Major Developments 319Contact Details 320EPIRUS Biopharmaceuticals 321Snapshot321Background 321Products321Major Developments 321Contact Details 322Exela 323Snapshot323Background 323Major Developments 323Contact Details 324Ferndale Pharma Group 325Snapshot325Background 325Products325Major Developments 326Contact Details 326Fougera327Snapshot327Background 327Products327Major developments 328Contact Details 329G&W Laboratories330Snapshot330Background 330Products330Contact Details 331GeneraMedix Pharmaceuticals332Snapshot332Background 332Products332Major Developments 333Contact Details 333Greenstone334Snapshot334Background 334Products334Major Developments 334Contact Details 335Handa Pharmaceuticals336Snapshot336xviii
Background 336
Products336
Major Developments 336
Contact Details 337
Hanford Pharmaceuticals338
Snapshot338
Background 338
Products338
Major Developments 338
Contact Details 339
Harris Pharmaceutical340
Snapshot 340
Background 340
Products 340
Contact Details 340
Hi-Tech Pharmacal 341
Snapshot341
Background 341
Products341
Financials 342
Major Developments 343
Contact Details 344
IGI Laboratories 345
Snapshot 345
Background 345
Products 345
Financials 345
Major Developments 346
Contact Details 346
Indicus Pharma347
Snapshot347
Background 347
Products347
Contact Details 348
InvaGen Pharmaceuticals349
Snapshot 349
Background 349
Products 349
Contact Details 350
Kadmon Pharmaceuticals 351
Snapshot351
Background 351
Products351
Major Developments 351
Contact Details 352
Kremers Urban Pharmaceuticals353
Snapshot353
Background 353
Products353
Major Developments 354
Contact Details 354
KVK-Tech 355
Snapshot355
Background 355
Products355
xix
Major Developments 355Contact Details 356Lehigh Valley Technologies357Snapshot357Background 357Products357Major Developments 357Contact Details 358Luitpold Pharmaceuticals359Snapshot359Background 359Products359Major Developments 361Contact Details 362Lyne Laboratories363Snapshot 363Background 363Products 363Contact Details 363Mallinckrodt364Snapshot 364Background 364Products 364Major Developments 365Contact Details 366Mikart367Snapshot367Background 367Products367Contact Details 368Nexgen Pharma369Snapshot 369Background 369Products 369Contact Details 369Nexus Pharmaceuticals370Snapshot370Background 370Products370Major Developments 370Contact Details 371Nostrum Pharmaceuticals372Snapshot372Background 372Products372Major Developments 372Contact Details 373Novel Laboratories 374Snapshot374Background 374Products374Major Developments 375Contact Details 375Orit Laboratories 376Snapshot376xx
Background 376
Products376
Contact Details 376
Osmotica Pharmaceutical377
Snapshot377
Background 377
Products377
Major Developments 378
Contact Details 378
Patheon379
Snapshot379
Background 379
Products379
Financials 380
Major Developments 381
Contact Details 382
Pharmaceutical Associates 383
Snapshot 383
Background 383
Products 383
Contact Details 383
Prasco Laboratories384
Snapshot 384
Background 384
Products 384
Major Developments 384
Contact Details 386
Precision Dose387
Snapshot 387
Background 387
Products 387
Major Developments 387
Contact Details 388
Qualitest Pharmaceuticals 389
Snapshot 389
Background 389
Products 389
Financials 391
Major Developments 392
Contact Details 392
Roxane Laboratories 393
Snapshot393
Background 393
Products393
Major Developments 395
Contact Details 396
Sigmapharm Laboratories 397
Snapshot397
Background 397
Products397
Contact Details 397
Silarx Pharmaceuticals 398
Snapshot 398
Background 398
Products 398
xxi
Contact Details 398SOHM399Snapshot 399Background 399Products 399Financials 399Major Developments 400Contact Details 401Spear Pharmaceuticals402Snapshot 402Background 402Products 402Major Developments 402Contact Details 402Stason Pharmaceuticals403Snapshot 403Background 403Products 403Major Developments 403Contact Details 404Tolmar 405Snapshot 405Background 405Products 405Major Developments 405Contact Details 406Tris Pharma407Snapshot 407Background 407Products 407Major Developments 408Contact Details 408Upsher-Smith Laboratories409Snapshot 409Background 409Products 409Major Developments 410Contact Details 410VersaPharm411Snapshot411Background 411Products411Contact Details 412VistaPharm 413Snapshot413Background 413Products413Contact Details 413X-GEN Pharmaceutical 414Snapshot414Background 414Products414Major Developments 414Contact Details 415xxii
Vietnam416
Nanogen Biopharmaceutical 416
Snapshot416
Background 416
Products416
Contact Details 416
To order this report: Generic Drugs: Global collaboration opportunities http://www.reportlinker.com/p0703654/Generic-Drugs-Global-collaboration-opportunities .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Generic_Drug
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article